Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Evaluating Home Testing Devices for the Management of Glaucoma
NCT05325996 · View on ClinicalTrials.gov ↗
Study Summary
With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Standard Automatic Perimetry Humphrey Field Analyzer
- DIAGNOSTIC_TEST visuALL H
- DIAGNOSTIC_TEST iCare Home Tonometer
- DIAGNOSTIC_TEST Spectralis Optical coherence tomography (OCT)
Study Locations (1)
Pennsylvania
- Wills Eye Hospital — Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2025-02-17 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05325996
The ClinicalTrials.gov registry entry for NCT05325996 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 12 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Glaucoma, Open-Angle appearing as the primary indexed condition, and to 4 interventions — of which Standard Automatic Perimetry Humphrey Field Analyzer is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05325996 reports 1 study location spanning 1 distinct geographic area — top geographies include Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05325996 about?
NCT05325996 is a clinical study titled "Evaluating Home Testing Devices for the Management of Glaucoma". With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimet...
What is the current status of trial NCT05325996?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2022-04-15. Estimated completion is 2025-02-17.
What conditions does trial NCT05325996 study?
This clinical trial studies the following conditions: Glaucoma, Open-Angle. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05325996?
The interventions under investigation include: Standard Automatic Perimetry Humphrey Field Analyzer (DIAGNOSTIC_TEST), visuALL H (DIAGNOSTIC_TEST), iCare Home Tonometer (DIAGNOSTIC_TEST), Spectralis Optical coherence tomography (OCT) (DIAGNOSTIC_TEST). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05325996?
This trial is sponsored by Wills Eye, which has 12 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05325996 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.